ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,540,260 | -17.3% | 140,663 | -0.0% | 0.00% | – |
| Q2 2023 | $1,863,093 | -67.8% | 140,717 | -66.9% | 0.00% | – |
| Q1 2023 | $5,790,102 | -16.5% | 425,430 | +19.8% | 0.00% | -100.0% |
| Q4 2022 | $6,933,111 | -18.5% | 354,998 | -20.5% | 0.00% | 0.0% |
| Q3 2022 | $8,502,000 | -4.3% | 446,277 | +3.5% | 0.00% | 0.0% |
| Q2 2022 | $8,883,000 | -55.0% | 431,196 | -29.7% | 0.00% | -50.0% |
| Q1 2022 | $19,744,000 | -46.7% | 613,537 | -22.9% | 0.00% | -33.3% |
| Q4 2021 | $37,038,000 | +70.4% | 795,481 | -1.2% | 0.00% | +50.0% |
| Q3 2021 | $21,737,000 | +4.5% | 805,081 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $20,797,000 | -25.8% | 810,781 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $28,030,000 | +12.5% | 820,081 | +11.3% | 0.00% | 0.0% |
| Q4 2020 | $24,921,000 | +58.3% | 736,881 | +15.5% | 0.00% | 0.0% |
| Q3 2020 | $15,744,000 | – | 638,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |